A Scanner-Integrated Decision Support Solution for Optimized Protocol Selection in Coronary Angiography with Photon-Counting CT
Author Block: C. Schuppert1, S. Barus1, M. Soschynski1, T. Allmendinger2, F. Bamberg1, T. Krauß1, C. L. Schlett1; 1Freiburg/DE, 2Forchheim/DE
Purpose: Photon-counting CT (PCCT) introduces novel scan modes that assist coronary CT angiography (CCTA) but increase protocol complexity. We developed and evaluated a scanner-integrated decision support solution to optimize protocol selection.
Methods or Background: In this prospective, two-center study, adult patients referred for CCTA were scanned on identical dual-source PCCT systems (NAEOTOM Alpha, Siemens Healthineers) with standard preparation. One site used the decision support solution (myExamCompanion, Siemens Healthineers), whereas the control site relied on conventional operator-driven protocol selection. Patient flow was not controlled. The decision support solution considered pre- and intra-scan input parameters reflecting coronary artery disease risk and cardiac dynamics (age, BMI, stents, Agatston score, heart rate, heart rate variability). Guided by the principle of “minimized exposure, full diagnostic performance”, it automatically selected from Quantum (70/90 kVp), Quantum Plus (120/140 kVp), Ultra High-Resolution (UHR), and Spectral UHR acquisition modes, as well as ECG-gating strategies (high-pitch spiral, prospective sequence, retrospective spiral). Evaluation focused on radiation dose, diagnostic confidence, and image quality, as measured by coronary signal-to-noise ratio (SNR) in a low-risk subset.
Results or Findings: A total of 1,304 patients underwent CCTA, with 727 (56%) scanned using the decision support solution. Baseline patient characteristics were comparable between groups. Use of the decision support solution was associated with lower dose length product (median 269 vs. 370 mGycm), mainly through greater Quantum mode utilization (34% vs. 11%). SNR was slightly lower in Quantum vs. Quantum Plus mode (median 15.3 vs. 17.7, p=0.07). The incidence of CAD-RADS≥3 was 21% vs. 29% with vs. without the solution, while CAD-RADS N was <1% in both groups.
Conclusion: The decision support solution optimizes PCCT protocol selection for CCTA, preserving image quality and interpretability while lowering radiation dose.
Limitations: Single-vendor, two-center study with site-based, non-randomized allocation.
Funding for this study: No funding was provided for this study.
Has your study been approved by an ethics committee? Yes
Ethics committee - additional information: Ethics Committee of the Medical Center – University of Freiburg (No. 21-1469, approved on September 21, 2021, and amendments).